RevealDx Receives FDA Clearance for AI-Powered Lung Nodule Risk Assessment

RevealDx has secured FDA clearance for RevealAI-Lung, an AI-driven software that helps radiologists assess incidental lung nodules using a validated malignancy scoring system. Trained and tested on data from more than 1,500 patients, the tool integrates directly into PACS, improves diagnostic confidence, and is now reimbursable by Medicare for US clinical use.